These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 23351040
21. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites. Wang WW, Khetani SR, Krzyzewski S, Duignan DB, Obach RS. Drug Metab Dispos; 2010 Oct; 38(10):1900-5. PubMed ID: 20595376 [Abstract] [Full Text] [Related]
23. [Metabolites of injected chlorogenic acid in rats]. Xie C, Zhong DF, Chen XY. Yao Xue Xue Bao; 2011 Jan; 46(1):88-95. PubMed ID: 21465813 [Abstract] [Full Text] [Related]
24. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach. Korolev D, Balakin KV, Nikolsky Y, Kirillov E, Ivanenkov YA, Savchuk NP, Ivashchenko AA, Nikolskaya T. J Med Chem; 2003 Aug 14; 46(17):3631-43. PubMed ID: 12904067 [Abstract] [Full Text] [Related]
27. Recent highlights of metabolomics for traditional Chinese medicine. Zhang A, Sun H, Wang X. Pharmazie; 2012 Aug 14; 67(8):667-75. PubMed ID: 22957430 [Abstract] [Full Text] [Related]
28. Metabolism of saikosaponin a in rats: diverse oxidations on the aglycone moiety in liver and intestine in addition to hydrolysis of glycosidic bonds. Liu G, Tian Y, Li G, Xu L, Song R, Zhang Z. Drug Metab Dispos; 2013 Mar 14; 41(3):622-33. PubMed ID: 23277344 [Abstract] [Full Text] [Related]
29. Classification of metabolites with kernel-partial least squares (K-PLS). Embrechts MJ, Ekins S. Drug Metab Dispos; 2007 Mar 14; 35(3):325-7. PubMed ID: 17142559 [Abstract] [Full Text] [Related]
33. Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites. Dalvie D, Obach RS, Kang P, Prakash C, Loi CM, Hurst S, Nedderman A, Goulet L, Smith E, Bu HZ, Smith DA. Chem Res Toxicol; 2009 Feb 14; 22(2):357-68. PubMed ID: 19146377 [Abstract] [Full Text] [Related]
34. An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs. Perola E. J Med Chem; 2010 Apr 08; 53(7):2986-97. PubMed ID: 20235539 [Abstract] [Full Text] [Related]
35. In vivo metabolism study of rhubarb decoction in rat using high-performance liquid chromatography with UV photodiode-array and mass-spectrometric detection: a strategy for systematic analysis of metabolites from traditional Chinese medicines in biological samples. Song R, Xu L, Xu F, Li Z, Dong H, Tian Y, Zhang Z. J Chromatogr A; 2010 Nov 05; 1217(45):7144-52. PubMed ID: 20889158 [Abstract] [Full Text] [Related]
37. Identification and characterization of reactive metabolites in natural products-driven drug discovery. Njuguna NM, Masimirembwa C, Chibale K. J Nat Prod; 2012 Mar 23; 75(3):507-13. PubMed ID: 22296642 [Abstract] [Full Text] [Related]
38. Do Fukui function maxima relate to sites of metabolism? A critical case study. Beck ME. J Chem Inf Model; 2005 Mar 23; 45(2):273-82. PubMed ID: 15807488 [Abstract] [Full Text] [Related]
39. Synthesis and characterization of some new phase II metabolites of the alkylator bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinoma. Teichert J, Sohr R, Baumann F, Hennig L, Merkle K, Caca K, Preiss R. Drug Metab Dispos; 2005 Jul 23; 33(7):984-92. PubMed ID: 15845750 [Abstract] [Full Text] [Related]